title: Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis.
abstract: Actinic keratoses (AKs) are on a continuum of progression to squamous cell carcinoma (SCC). The most common AK treatment modalities are lesion-directed cryosurgery and field-directed therapy with 5-fluorouracil (5-FU); however, side effects can affect patient compliance. This study was performed to determine the efficacy and perceived side effects of combination treatment with cryosurgery and a shortened course of 5-FU cream 0.5% for AK lesions. Sixty participants with AK lesions underwent cryosurgery and were then randomized to apply 5-FU cream 0.5% or comparator cream once daily to the study area for 1 week. Participants were evaluated at weeks 3, 4, 8, and 26. After 8 weeks, treatment with cryosurgery and 5-FU cream 0.5% was more likely to result in complete clearance versus cryosurgery alone; however, no statistical difference was found in the complete clearance of AK lesions in the treatment group compared to cryosurgery alone at 26 weeks, while side effects in the treatment group were decreased. This study demonstrated the benefit of combination treatment of cryosurgery with 1 week of 5-FU compared to cryosurgery alone in clearing AK lesions for 2 months. This study shows promise for future studies with larger sample sizes to illustrate increased efficacy and decreased side effects with combination treatment of AKs with cryosurgery and 5-FU.
authors.forename: William D
authors.initials: WD
authors.lastname: Hoover
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Jorizzo
authors.affiliation: Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA. adclark@wakehealth.edu.
authors.forename: Adele R
authors.initials: AR
authors.lastname: Clark
authors.forename: Steven R
authors.initials: SR
authors.lastname: Feldman
authors.forename: Judy
authors.initials: J
authors.lastname: Holbrook
authors.forename: Karen E
authors.initials: KE
authors.lastname: Huang
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000517:prevention & control*; D003131:Combined Modality Therapy; D003452:Cryosurgery / Q000379:methods*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D055623:Keratosis, Actinic / Q000150:complications / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D063465:Skin Cream; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil